BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27273257)

  • 1. Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway.
    Huang WL; Li Z; Lin TY; Wang SW; Wu FJ; Luo CW
    Sci Rep; 2016 Jun; 6():27471. PubMed ID: 27273257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary.
    Sun SC; Hsu PJ; Wu FJ; Li SH; Lu CH; Luo CW
    J Biol Chem; 2010 Feb; 285(6):3758-3765. PubMed ID: 19955180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thyrostimulin and its potential clinical significance.
    Karponis D; Ananth S
    Endocr Regul; 2017 Apr; 51(2):117-128. PubMed ID: 28609287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Characterization of Thyrostimulin in Amphioxus Suggests an Ancestral Origin of the TH Signaling Pathway.
    Wang P; Liu S; Yang Q; Liu Z; Zhang S
    Endocrinology; 2018 Oct; 159(10):3536-3548. PubMed ID: 30192937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway.
    Choi JH; Chen CL; Poon SL; Wang HS; Leung PC
    Endocr Relat Cancer; 2009 Mar; 16(1):179-88. PubMed ID: 19022848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells.
    Reddy P; Liu L; Ren C; Lindgren P; Boman K; Shen Y; Lundin E; Ottander U; Rytinki M; Liu K
    Mol Endocrinol; 2005 Oct; 19(10):2564-78. PubMed ID: 15928314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
    Reimer D; Hubalek M; Riedle S; Skvortsov S; Erdel M; Concin N; Fiegl H; Müller-Holzner E; Marth C; Illmensee K; Altevogt P; Zeimet AG
    Cancer Res; 2010 Jun; 70(11):4613-23. PubMed ID: 20460525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
    D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
    J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
    Ling Poon S; Lau MT; Hammond GL; Leung PC
    Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
    Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
    Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of functional HER family members increases the sensitivity to docetaxel in human ovarian cancer cell lines.
    Bijman MN; van Berkel MP; Kok M; Janmaat ML; Boven E
    Anticancer Drugs; 2009 Jul; 20(6):450-60. PubMed ID: 19369859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the thyrostimulin subunits, glycoprotein alpha2 and beta5 in the rat pituitary.
    Nagasaki H; Wang Z; Jackson VR; Lin S; Nothacker HP; Civelli O
    J Mol Endocrinol; 2006 Aug; 37(1):39-50. PubMed ID: 16901922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
    Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
    Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor.
    Nakabayashi K; Matsumi H; Bhalla A; Bae J; Mosselman S; Hsu SY; Hsueh AJ
    J Clin Invest; 2002 Jun; 109(11):1445-52. PubMed ID: 12045258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
    Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
    Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ancestral glycoprotein hormone-receptor pathway controls growth in
    Kenis S; Istiban MN; Van Damme S; Vandewyer E; Watteyne J; Schoofs L; Beets I
    Front Endocrinol (Lausanne); 2023; 14():1200407. PubMed ID: 37409228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C; Völker P; Emons G
    Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.